News

Former Editor, The Wall Street Journal
James Willhite was an editor with The Wall Street Journal's money & investing team based in London.
Reporter, Ottawa Bureau, The Wall Street Journal
Paul Vieira covers Canada for The Wall Street Journal, and is based in Ottawa.
The Munich Eye7h
Novavax's COVID-19 Vaccine Advances Towards Full FDA Approval
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Wyoming Tribune Eagle20h
HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Zacks Investment Research on MSN23h
Can Moderna Keep the Beat Streak Alive This Earnings Season?
Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...
Novavax told by FDA to conduct additional study for COVID vaccine - report
The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...
Indiatimes18h
Azad Engineering Share Price
Azad Engineering Ltd., incorporated in the year 1983, is a Small Cap company (having a market cap of Rs 9,717.61 Crore) operating in Engineering sector. Azad Engineering Ltd. key Products/Revenue ...